玻璃体内注射曲安奈德治疗糖尿病性弥漫性黄斑水肿的护理

Observation on triamcinolone acetonide injection in vitreous body to treat diffuse macular edema of patients with diabetic mellitus

目的探讨玻璃体腔注射曲安奈德(TA)治疗糖尿病性弥漫性黄斑水肿的护理。方法对48例(60眼)经检眼镜检查、荧光素眼底血管造影(FFA)和光相干断层扫描(OCT)检查确诊的糖尿病性弥漫性黄斑水肿患者,接受玻璃体内注射4 mg/0.1 ml的TA治疗,做好术前患者的心理护理,注射后加强并发症的观察,尤其是眼压的监测。结果48例(60眼)患者经治疗后视力提高42眼,OCT检查黄斑区视网膜厚度平均降低143μm,随访期间无复发。结论加强注射前、中、后护理,尤其是糖尿病患者饮食指导及预防并发症的护理,对确保该技术的治疗效果非常重要。

Objective To explore the nursing on triamcinolone acetonide injection in vitreous body to treat diffuse macular edema of patients with diabetic mellitus. Methods 48 patients （60 eyes） with diffuse diabetic macular edema were diagnosed by ophthalmolscopy, fluorescein fundus angiography and optical coherent tomography. They were treated by intravitreal triamcinolone acetonide injection （4mg/ 0. lml）, The psychological nursing was emphasized and the complications, especially intraocular pressure, were observed. Results 42 eyes were improved in visual acuity in all 48 cases （60 eyes）. The macular retinal thickness was reduced 143 μm measured by optical coherent tomography. No relapse was observed in the follow- up study. Conclusions It is very important for assuring the treatment efficacy to enhance the peri-injection nursing, especially the guidance of diabetic diet and nursing on complication prevention.